BIOMAT Database Logo BIOMAT Database Logo

[Effect of propranolol (inderal), a new specific blocking agent of adrenergic betareceptors, on effort tolerance in angina pectoris]. 1966

T Grandjean, and N J Hamer, and G Sowton, and L Melendez

UI MeSH Term Description Entries
D011433 Propranolol A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs. Dexpropranolol,AY-20694,Anaprilin,Anapriline,Avlocardyl,Betadren,Dociton,Inderal,Obsidan,Obzidan,Propanolol,Propranolol Hydrochloride,Rexigen,AY 20694,AY20694,Hydrochloride, Propranolol
D005082 Physical Exertion Expenditure of energy during PHYSICAL ACTIVITY. Intensity of exertion may be measured by rate of OXYGEN CONSUMPTION; HEAT produced, or HEART RATE. Perceived exertion, a psychological measure of exertion, is included. Physical Effort,Effort, Physical,Efforts, Physical,Exertion, Physical,Exertions, Physical,Physical Efforts,Physical Exertions
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000787 Angina Pectoris The symptom of paroxysmal pain consequent to MYOCARDIAL ISCHEMIA usually of distinctive character, location and radiation. It is thought to be provoked by a transient stressful situation during which the oxygen requirements of the MYOCARDIUM exceed that supplied by the CORONARY CIRCULATION. Angor Pectoris,Stenocardia,Stenocardias

Related Publications

T Grandjean, and N J Hamer, and G Sowton, and L Melendez
[Propranolol (a new beta adrenergic blocking agent) in angina pectoris].
January 1967, Archivos del Instituto de Cardiologia de Mexico,
T Grandjean, and N J Hamer, and G Sowton, and L Melendez
A new beta adrenergic blocking agent, propranolol, in the treatment of angina pectoris.
February 1968, Canadian Medical Association journal,
T Grandjean, and N J Hamer, and G Sowton, and L Melendez
[Result of a beta-adrenergic (propranolol) blocking agent in angina pectoris].
August 1967, Arquivos brasileiros de cardiologia,
T Grandjean, and N J Hamer, and G Sowton, and L Melendez
Metabolism of propranolol ('Inderal'), a potent, specific beta-adrenergic receptor blocking agent.
February 1967, Nature,
T Grandjean, and N J Hamer, and G Sowton, and L Melendez
The effects of a new adrenergic blocking agent (K4423) on exercise tolerance in angina pectoris.
January 1973, Cardiology,
T Grandjean, and N J Hamer, and G Sowton, and L Melendez
[USE OF A BETA ADRENERGIC BLOCKING AGENT IN ANGINA PECTORIS].
February 1965, La Clinica terapeutica,
T Grandjean, and N J Hamer, and G Sowton, and L Melendez
[Our experience with a new beta-adrenergic blocking agent (Practolol) in angina pectoris].
January 1973, Revista espanola de cardiologia,
T Grandjean, and N J Hamer, and G Sowton, and L Melendez
DOUBLE-BLIND TRIAL OF PROPRANOLOL (INDERAL) IN ANGINA PECTORIS.
April 1965, British medical journal,
T Grandjean, and N J Hamer, and G Sowton, and L Melendez
Orthostatic ECG changes and the adrenergic beta-receptor blocking agent, propranolol (Inderal).
October 1965, Acta medica Scandinavica,
T Grandjean, and N J Hamer, and G Sowton, and L Melendez
[Use of a new beta-adrenergic blocking agent in angina pectoris patients (Ba 39'089)].
June 1968, Prensa medica argentina,
Copied contents to your clipboard!